School of Medicine

Photo by Robert BostonAyodele Adesanya, a University of Chicago undergraduate who took part in the summer Biomedical Research Apprenticeship Program (BioMed RAP), talks about his research poster, “Gene expression and polymorphism in the GAL1 promoter of Saccharomyces” with Yue Yun, a doctoral student in the Computational Biology Program.

Anita L. Minor tells of her gift of a child with Down Syndrome in a recently released book.

A molecular factor involved in maintaining the heart’s energy supply could become a key to new approaches to prevent or treat heart failure, School of Medicine researchers have found.

Courtesy PhotoJeffrey Lowell, M.D., (left) and Eric Shirley, lieutenant commander in the U.S. Navy, perform clubfoot repair surgery on a child while on board the USNS Comfort.Jeffrey Lowell, M.D., was deployed on the military hospital ship USNS Comfort this month to serve as a general surgeon while the ship was in Central America.

Project ARK has received a $6.7 million, five-year grant from the U.S. Department of Health and Human Services.

Rosalind Kornfeld, a pioneer among women in science, died Friday, Aug. 10, after a long illness. She was 72.

School of Medicine scientists have identified the first gene for itching, which could rapidly lead to new treatments and relief for chronic and severe itching.

Poor housing conditions contribute to the risk for diabetes in urban, middle-aged African-Americans, researchers have discovered.

The School of Medicine has joined the Multiple Myeloma Research Consortium (MMRC), an organization of 13 leading U.S. academic centers designed to speed the development of new myeloma therapies. Washington University School of Medicine serves as a major center for multiple myeloma treatment and research in the St. Louis area.

Mice developed in the laboratory of Zhou-Feng Chen don’t experience relief from pain when given opiate drugs such as morphine.For the first time, pain researchers at the School of Medicine have shown that it’s possible to separate the good effects of opiate drugs such as morphine (pain relief) from the unwanted side effects of those drugs (tolerance, abuse and addiction). The investigators, led by Zhou-Feng Chen, Ph.D., associate professor of anesthesiology, psychiatry and molecular biology and pharmacology, report their results online in the Proceedings of the National Academy of Sciences. They found that opiates like morphine don’t relieve pain as well in mice genetically engineered to lack neurons that produce a neurotransmitter called serotonin in the central nervous system.